18 results
Creon (pancrelipase)
(Pancrelipase)AbbVie Inc.
Usage: CREON® is indicated for treating exocrine pancreatic insufficiency in both adult and pediatric patients.
Depakote (divalproex sodium)
(Divalproex Sodium)AbbVie Inc.
Usage: Depakote ER is indicated for the treatment of acute manic or mixed episodes related to bipolar disorder, complex partial seizures, and for the prophylaxis of migraine headaches. It should not be used in pregnant women or those of childbearing potential without effective contraception due to potential fetal risks.
Depakote (divalproex sodium)
(Divalproex Sodium)AbbVie Inc.
Usage: Depakote (divalproex sodium) is indicated for treating manic episodes of bipolar disorder, epilepsy (as monotherapy or adjunctive therapy for various seizures), and for migraine headache prophylaxis. Long-term efficacy in mania is unproven beyond three weeks, and it poses risks during pregnancy, particularly affecting fetal development.
Duopa (carbidopa and levodopa)
(Carbidopa and Levodopa)AbbVie Inc.
Usage: DUOPA® is indicated for treating motor fluctuations in patients with advanced Parkinson’s disease.
Gengraf (cyclosporine)
(Cyclosporine)AbbVie Inc.
Usage: Gengraf® (cyclosporine oral solution, USP [MODIFIED]) is indicated for the prevention of organ rejection in kidney, liver, and heart transplants, as well as for treating severe active rheumatoid arthritis unresponsive to methotrexate and severe plaque psoriasis in adults who have failed prior systemic therapies.
Humira (adalimumab)
(Adalimumab)AbbVie Inc.
Usage: HUMIRA is indicated for treating various conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in patients aged 2 and older, either alone or with other therapies.
Lupron depot (leuprolide acetate)
(leuprolide acetate)AbbVie Inc.
Usage: LUPRON DEPOT 11.25 mg is indicated for managing endometriosis (pain relief and lesion reduction) and, when combined with norethindrone acetate, for symptom management. It also prepares women with anemia due to uterine fibroids for surgery, enhancing hematologic improvement alongside iron therapy. Total therapy duration should not exceed 12 months.
Mavyret (glecaprevir and pibrentasvir)
(Glecaprevir and Pibrentasvir)AbbVie Inc.
Usage: MAVYRET is indicated for treating chronic hepatitis C virus (HCV) genotypes 1-6 in patients aged 3 and older, including those with or without cirrhosis. It is also for patients with HCV genotype 1 who have previously received treatment with an NS5A inhibitor or an NS3/4A protease inhibitor.
Norvir (ritonavir)
(Ritonavir)AbbVie Inc.
Usage: NORVIR is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, applicable for both adults (tablets) and pediatric patients (oral powder).
Oriahnn (elagolix and estradiol and norethisterone)
(Elagolix and Estradiol and Norethisterone)AbbVie Inc.
Usage: ORIAHNN is indicated for managing heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women. It is recommended for use up to 24 months due to the risk of potential irreversible bone loss.